Galmed Pharmaceuticals Ltd. buy Roth Mkm
Start price
17.12.24
/
50%
€6.40
Target price
17.12.25
€109.50
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 17.12.25. The prediction end date can be changed by Roth_Mkm at any time.Performance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Galmed Pharmaceuticals Ltd. | - | - |
| iShares Core DAX® | 0.734% | 1.458% |
| iShares Nasdaq 100 | -2.686% | -0.146% |
| iShares Nikkei 225® | -2.261% | -2.729% |
| iShares S&P 500 | -1.346% | 0.467% |
Comments by Roth_Mkm for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical, Inc. (NYSE: GMED) had its price target raised by analysts at Roth Mkm from $100.00 to $115.00. They now have a "buy" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Roth_Mkm for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
06.11.24
06.11.24
€93.12
06.11.25
06.11.25
-
07.11.25
07.11.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.39
20.10.23
20.10.23
€70.85
20.10.24
20.10.24
1558.03%
21.10.24
21.10.24